RSV-Associated Hospitalizations among American Indian and Alaska Native Children in Alaska and the Southwest United

Rachel M Hartman1, Catherine G Sutcliffe1,2, James Keck3

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Insights

Acute respiratory infections remain a significant threat to young American Indian/Alaska Native children. High rates of respiratory syncytial virus hospitalizations highlight the urgent need for effective prevention strategies.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public Health

Background:

  • American Indian/Alaska Native (AI/AN) children under 5 years old face disproportionately high rates of acute respiratory infections.
  • Respiratory syncytial virus (RSV) is a leading cause of hospitalization in these vulnerable pediatric populations.
  • Existing prevention measures may not be sufficient, necessitating ongoing surveillance.

Purpose of the Study:

  • To conduct active surveillance for acute respiratory infections (ARIs) in hospitalized AI/AN children younger than 5 years.
  • To identify the burden of specific respiratory pathogens, such as RSV, in this demographic.
  • To inform the development and implementation of targeted prevention products and strategies.

Main Methods:

  • Active surveillance was implemented at select healthcare facilities in Alaska and the Southwestern United States.
  • Data collection focused on hospitalized AI/AN children aged less than 5 years presenting with acute respiratory illness.
  • Epidemiological data on ARI incidence and pathogen identification were systematically gathered.

Main Results:

  • Hospitalized AI/AN children under 5 years experienced high rates of acute respiratory infections.
  • Respiratory syncytial virus was identified as a major contributor to hospitalizations in this cohort.
  • The findings underscore a persistent public health challenge in these communities.

Conclusions:

  • AI/AN children under 5 years continue to face a substantial burden of ARI, particularly RSV.
  • The high hospitalization rates emphasize the critical need for novel and improved prevention products.
  • Continued surveillance and research are essential to mitigate respiratory disease impact in AI/AN children.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...